MSB 3.21% $1.13 mesoblast limited

I agree and they seem to be specific asking for heart patients,...

  1. 1,321 Posts.
    lightbulb Created with Sketch. 145
    I agree and they seem to be specific asking for heart patients, the broader Trial would not limit the type of patient. The positive is that it might be of significant benefit to heart patients and therefor offer another opportunity to Mesoblast.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.